BLACKSBURG, Va.--(BUSINESS WIRE)--Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, announced today it has received an additional $10 million of Series C-2 financing from New River Management V, LP, (NRM-V) a life sciences focused investment fund managed by Third Security, LLC. This is the final investment for NRM-V, which is now fully committed. Third Security intends to continue its investment strategy with a new fund, New River Management VI.
